Clinical Services

Plasma treatment for healing chronic wounds

20 February, 2024

More than 420,000 Australians suffer from a chronic wound each year, costing the health and aged care system a total of $3bn.


Digital therapy reduces distress in long-term conditions

15 February, 2024

People living with long-term conditions who received the therapist-guided digital program have showed a significant reduction in psychological distress.


The state of paediatric palliative care in Australia

15 February, 2024

150 km. That's the average distance between paediatric palliative care patients and the children's hospital at which they received specialist care.


Cryptosporidiosis cases on the rise

14 February, 2024

The gastrointestinal disease caused by the microscopic parasite Cryptosporidium is a common cause of acute diarrhoea in young children.


Bridging the maternal care gap

14 February, 2024 by Deepak Biswal*

In 2021, around 46% of first-time mothers had a postnatal stay of less than one day, according to new data from the Australian Institute of Health and Welfare (AIHW).


Getinge Neurally Adjusted Ventilatory Assist (NAVA)

13 February, 2024 | Supplied by: Getinge Australia Pty Ltd

Getinge's Neurally Adjusted Ventilatory Assist was developed to use the patient's own neural respiratory drive to control the ventilator.


Aust research driving global postpartum haemorrhage guidelines

09 February, 2024

More than 14 million women globally experience postpartum haemorrhage, resulting in 70,000 maternal deaths a year.


Hypertension guidelines must include salt substitues: research

07 February, 2024

In Australia and New Zealand, most people consume excessive amounts of sodium, with the estimated average said to be about 3600 mg/day


Study lists 16 potentally risky medicines in Aust health care

06 February, 2024

Researchers from the RMIT have developed a list of potentially dangerous medications used in Australia and have also suggested safer alternatives.


How to shield breast cancer patients from lymphoedema

06 February, 2024

Global researchers have published a clinical guide on how and where to roll out evidence-based interventions to help prevent lymphoedema for cancer survivors.


A new weapon against C. diff bacteria

01 February, 2024

In a phase-one human clinical trial, a US pharmacist researcher has shown that a newer generation tetracycline antibiotic could help combat Clostridioides difficile (C. diff) bacteria.


Making cancer outcome equity a reality

01 February, 2024

Christine Cockburn, CEO, Rare Cancers Australia, reflects on care disparities across populations and the role of personalised medicine in improving outcomes.


Providing better access and more choice for cancer care

01 February, 2024

Cancer patients undergoing treatment on Brisbane's northside are set to benefit from a new, multimillion-dollar onsite radiation therapy service.


Anti-psychotic medications and the risk of heart rhythm disorders

31 January, 2024

Around 350,000 Australians are prescribed at least one anti-psychotic drug each year, prompting calls to better monitor patients and perform ECGs.


Cannatrek signs MoU to advance medicinal cannabis research

31 January, 2024

Cannatrek has signed an agreeent with Mie University in Tsu, Japan, to forge an open collaboration focused on accelerating medical research.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd